| Literature DB >> 35162396 |
Yulia Varakina1, Andrey Aksenov1, Dmitry Lakhmanov2, Anna Trofimova1, Rimma Korobitsyna1, Natalia Belova1,3, Dmitry Kotsur1,4, Tatiana Sorokina1, Andrej M Grjibovski1,3,5,6, Ludmila Popova7, Valery Chashchin1,8,9, Jon Øyvind Odland10,11, Yngvar Thomassen1,9,12.
Abstract
The overwhelming majority of Arctic biomonitoring studies in humans include either pregnant or non-pregnant women of reproductive age while little attention is paid to toxic compounds concentrations in men. This study contributes with information of the present amounts of persistent organic pollutants (POPs) in men living in Arctic Russia. We studied the serum concentrations of 11 polychlorinated biphenyl (PCB) congeners and 17 organochlorine pesticides (OCPs) and some of their metabolites in samples collected from 92 adult men (mean age 43 years) from seven different settlements in Nenets Autonomous Okrug (NAO). The median concentrations of individual PCB congeners increased in the order PCB 183, PCB 180, PCB 118, PCB 138, PCB 153. The concentrations of o, p'-DDD, p, p'-DDD, aldrin, mirex and 1,2,3,5-TCB were in most cases below the quantification limit. The observed concentrations of PCBs and chlorinated pesticides were in the same range as those found in similar groups of women of these territories, but lower than of men in other Arctic countries. However, significant geographic differences between the settlements were observed with exceptionally high concentrations of PCBs in the Islands group. The highest serum ∑PCBs and β-HCH levels were observed in adult males aged 60-78 years. We found significant variations in serum concentrations of POPs across settlements and ethnic groups with exceptionally high concentrations of PCBs among the residents of the Arctic islands. At the same time, our findings suggest a considerable decrease in serum concentration of POPs over the last decade.Entities:
Keywords: PCBs; Russian Arctic; biomonitoring; indigenous peoples; men; pesticides
Mesh:
Substances:
Year: 2022 PMID: 35162396 PMCID: PMC8835178 DOI: 10.3390/ijerph19031379
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Location of the study settlements, number of study participants and proportion of the total male population. The map was created using CorelDRAW Graphics Suite X4 software (license certificate No 30064931). (https://www.coreldraw.com/) (accessed on 20 July 2021); the topographic base of the map was created with Natural Earth Free Vector and Raster Map Data (https://www.naturalearthdata.com) (accessed on 20 July 2021).
Limit of detection (LOD), limit of quantification (LOQ) and the percentage of analytes detected in sample.
| Analyte | % > LOD a | LOD | LOQ | ||
|---|---|---|---|---|---|
| Range (ng/g Lipid) | Range (ng/g Lipid) | ||||
| PCB28 | - b | 0.40 | 1.14 | 1.80 | 5.07 |
| PCB52 | - | 2.92 | 8.24 | 9.74 | 27.5 |
| PCB101 | - | 4.11 | 11.6 | 13.7 | 38.6 |
| PCB105 | - | 5.92 | 16.7 | 19.7 | 55.6 |
| PCB118 | 18.5 | 8.20 | 19.3 | 23.9 | 67.4 |
| PCB123 | - | 4.43 | 12.5 | 14.8 | 41.6 |
| PCB128 | - | 4.22 | 11.9 | 14.1 | 39.7 |
| PCB138 | 42.4 | 9.50 | 22.4 | 27.8 | 78.4 |
| PCB153 | 83.7 | 2.52 | 5.95 | 7.38 | 20.8 |
| PCB180 | 58.7 | 1.23 | 2.90 | 3.59 | 10.1 |
| PCB183 | 5.43 | 5.49 | 12.9 | 16.1 | 45.3 |
| o, p′-DDE | 82.6 | 2.06 | 4.86 | 6.03 | 17.0 |
| p, p′-DDE | 90.2 | 10.9 | 25.7 | 31.9 | 89.9 |
| o, p′-DDD | 6.52 | 0.84 | 1.98 | 2.46 | 6.94 |
| p, p′-DDD | 34.8 | 4.78 | 11.3 | 14.0 | 39.5 |
| HCB | 98.9 | 3.50 | 8.25 | 10.2 | 28.9 |
| α-HCH | - | 5.59 | 15.8 | 18.6 | 52.5 |
| β-HCH | 96.7 | 2.00 | 4.71 | 5.84 | 16.5 |
| γ-HCH | - | 3.62 | 10.2 | 12.1 | 34.0 |
| cis-nonachlor | - | 3.51 | 9.91 | 11.7 | 33.0 |
| trans-nonachlor | 8.70 | 8.85 | 20.9 | 25.9 | 73.0 |
| cis-chlordane | - | 3.51 | 9.91 | 11.7 | 33.0 |
| trans-chlordane | - | 8.56 | 24.1 | 28.5 | 80.4 |
| Heptachlor | - | 7.68 | 21.7 | 25.6 | 72.2 |
| Aldrin | 6.52 | 9.53 | 22.5 | 21.7 | 61.2 |
| Mirex | 2.17 | 6.10 | 14.4 | 17.9 | 50.3 |
| 1,2,3,5-tetrachlorobenzene | 22.8 | 1.09 | 2.58 | 3.20 | 9.02 |
| 1,2,4,5-tetrachlorobenzene | - | 0.96 | 2.71 | 3.20 | 9.02 |
a % > LOD—the percentage of analytes detected above the limit of quantitative detection in the sample; b ”-“—no signal.
Background characteristics of the study participants, Nenets Autonomous Okrug, Arctic Russia.
| Characteristic | Measures | Islands | Shoina | Amderma | Indiga | Pechora | Nenets | Non-Nenets | ||
|---|---|---|---|---|---|---|---|---|---|---|
| N | 19 | 11 | 17 | 15 | 30 | 51 | 41 | |||
| Age, years | GM | 37.5 | 44.1 | 45.0 | 36.9 | 40.9 | 0.502 | 40.2 | 41.06 | 0.801 |
| Min | 18.0 | 28.0 | 28.0 | 19.0 | 20.0 | 20.0 | 18 | |||
| Max | 78.0 | 63.0 | 72.0 | 59.0 | 70.0 | 78.0 | 72 | |||
| Total lipid, mg/dL | GM | 578 | 599 | 627 | 560 | 595 | 0.615 | 588 | 597 | |
| Min | 395 | 459 | 468 | 414 | 417 | 395 | 414 | 0.485 | ||
| Max | 1110 | 859 | 977 | 821 | 874 | 1110 | 977 | |||
| BMI, (kg/m2) | GM | 25.0 | 27.4 | 28.3 | 27.7 | 25.2 | 0.018 | 26.1 | 26.7 | |
| Min | 19.8 | 20.5 | 19.7 | 19.4 | 20.8 | 19.8 | 19.4 | 0.719 | ||
| Max | 34.5 | 37.1 | 37.1 | 36.0 | 40.0 | 37.1 | 40.0 | |||
| BMI > 30, n (%) | 2 (10.5) | 2 (18.2) | 8 (47.1) | 6 (40) | 4 (13.3) | 10 (20) | 12 (29) | |||
| Proportion of Nenets, n (%) | 17 (89.5) | 1 (9.10) | 5 (29.4) | 6 (40.0) | 22 (73.3) |
ap-value for difference between the settlements calculated using one-way ANOVA.; bp-value for difference between the settings calculated using Student t-test.
Serum concentrations of POPs (ng/g lipids) in men of the Nenets Autonomous Okrug, Arctic Russia.
| Analyte | Measures | Islands | Shoina | Amderma | Indiga | Pechora | Total | Nenets | Non-Nenets | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 19 | 11 | 17 | 15 | 30 | 92 | 51 | 41 | |||
| PCBs, ng/g lipid | |||||||||||
| PCB 118 | GM | 8.24 | <LOD | 14.7 | 12.3 | <LOD | 9.08 | <LOD | 10.5 | ||
| Min | <LOD 5 | <LOD | <LOD | <LOD | <LOD | <0.001 | <LOD | <LOD | <LOD | 0.049 | |
| Max | 45.0 | 24.0 | 42.1 | 89.0 | <LOD | 89.0 | 45.0 | 89.0 | |||
| PCB 138 | GM | 37.7 | 30.7 | 19.1 | 12.8 | <LOD | 16.9 | 16.3 | 17.7 | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | <0.001 | <LOD | <LOD | <LOD | 0.489 | |
| Max | 515 | 96.8 | 60.0 | 163 | 54.6 | 515 | 515 | 163 | |||
| PCB 153 | GM | 90.4 | 41.6 | 31.5 | 12.7 | 8.34 | 22.7 | 27.5 | 17.8 | ||
| Min | <LOD | 8.84 | <LOD | <LOD | <LOD | <0.001 | <LOD | <LOD | <LOD | 0.156 | |
| Max | 2640 | 142 | 83.3 | 292 | 77.2 | 2640 | 2640 | 292 | |||
| PCB 180 | GM | 52.9 | 11.9 | 15.7 | 3.32 | <LOD | 5.82 | 5.84 | 5.80 | ||
| Min | 6.55 | 2.22 | <LOD | <LOD | <LOD | <0.001 | <LOD | <LOD | <LOD | 0.102 | |
| Max | 1420 | 37.4 | 52.4 | 118 | <LOD | 1420 | 1420 | 118 | |||
| PCB 183 | GM | 6.84 | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | - | <LOD | <LOD | <LOD | 0.064 | |
| Max | 45.6 | <LOD | <LOD | <LOD | <LOD | 45.6 | 45.6 | 6.03 | |||
| ∑ PCB5 1 | GM | 222 | 110 | 92.2 | 52.5 | 33.6 | 74.1 | 80.2 | 67.2 | ||
| Min | 28.8 | 35.1 | 20.6 | 18.9 | 15.0 | <0.001 | 15.0 | 19.3 | 15.0 | 0.165 | |
| Max | 4600 | 257 | 217 | 666 | 137 | 4600 | 4600 | 666 | |||
| OCPs ng/g lipid | |||||||||||
| o, p-DDE | GM | 21.7 | 23.0 | 6.57 | 3.81 | 18.6 | 12.6 | 13.0 | 12.0 | ||
| Min | 2.70 | 11.8 | <LOD | <LOD | <LOD | <0.001 | <LOD | <LOD | <LOD | 0.407 | |
| Max | 61.8 | 38.5 | 23.7 | 24.0 | 75.2 | 75.2 | 65.6 | 75.2 | |||
| p, p′-DDE | GM | 121 | 152 | 123 | 41.8 | 32.5 | 68.3 | 48.7 | 104 | ||
| Min | 30.6 | 43.3 | 22.7 | <LOD | <LOD | <0.001 | <LOD | <LOD | 16.0 | 0.009 | |
| Max | 467 | 549 | 1320 | 336 | 278 | 1320 | 467 | 1320 | |||
| o, p-DDD | GM | <LOD | <LOD | <LOD | <LOD | 0.99 | 0.92 | 0.86 | 1.00 | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | - | <LOD | <LOD | <LOD | 0.262 | |
| Max | <LOD | <LOD | <LOD | <LOD | 129 | 129 | 1.73 | 129 | |||
| p, p′-DDD | GM | <LOD | <LOD | <LOD | <LOD | 47.5 | 9.62 | 12.1 | 7.22 | ||
| Min | <LOD | <LOD | <LOD | <LOD | 17.3 | <LOD | <LOD | <LOD | 0.165 | ||
| Max | <LOD | <LOD | 8.41 | 6.03 | 183 | 183 | 183 | 109 | |||
| ∑ DDT 2 | GM | 161 | 193 | 146 | 55.0 | 124 | 125 | 109 | 146 | ||
| Min | 61.3 | 72.4 | 41.1 | 15.3 | 36.2 | 0.002 | 15.3 | 15 | 21.4 | 0.019 | |
| Max | 506 | 570 | 1321 | 342 | 534 | 1320 | 506 | 1321 | |||
| HCB | GM | 83.1 | 26.3 | 34.2 | 133 | 65.1 | 61.2 | 81.7 | 42.8 | ||
| Min | <LOD | 10.85 | 9.4 | 22.2 | 12.5 | <0.001 | <LOD | <LOD | 9.38 | 0.014 | |
| Max | 358 | 109 | 250 | 469 | 713 | 713 | 713 | 370 | |||
| β-HCH | GM | 13.2 | 26.4 | 17.1 | 19.8 | 12.7 | 15.9 | 13.2 | 19.9 | ||
| Min | 2.75 | 3.17 | 4.00 | 7.21 | 2.10 | 0.227 | 2.10 | 2.75 | 2.10 | 0.006 | |
| Max | 31.5 | 178 | 118 | 139 | 89.2 | 178 | 139 | 178 | |||
| Aldrin | GM | 18.1 | <LOD | <LOD | <LOD | <LOD | <LOD | 10.5 | <LOD | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | - | <LOD | <LOD | <LOD | 0.138 | |
| Max | 987 | <LOD | 24.6 | <LOD | <LOD | 987 | 987 | 24.6 | |||
| Mirex | GM | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | <LOD | 0.207 | ||
| Max | 36.6 | <LOD | <LOD | <LOD | <LOD | - | 36.6 | 36.6 | 7.24 | ||
| trans-nonachlor | GM | 11.9 | 9.60 | <LOD | <LOD | <LOD | <LOD | 9.05 | <LOD | ||
| Min | <LOD | <LOD | <LOD | <LOD | <LOD | - | <LOD | <LOD | <LOD | 0.207 | |
| Max | 95.7 | 34.8 | <LOD | 26.1 | <LOD | 95.7 | 95.7 | 34.8 | |||
| 1,2,3,5-TCB | GM | <LOD | <LOD | 1.73 | 64.9 | <LOD | 1.96 | 1.52 | 2.70 | ||
| Min | <LOD | <LOD | <LOD | 12.5 | <LOD | - | <LOD | <LOD | <LOD | 0.798 | |
| Max | <LOD | <LOD | 10.4 | 502 | <LOD | 502 | 502 | 250 | |||
1 sum PCB# 118, 138, 153, 180, 183; 2 sum p, p′-DDE, p, p′-DDD, o. p′-DDE. o, p′-DDD; 3
p-values calculated by Kruskal–Wallis test; 4
p-values for difference between the settlements calculated using Mann–Whitney test; 5
Crude coefficients (bc) and 95% confidence intervals (CI) for the associations between logarithmically transformed serum concentrations of legacy POPs and selected covariates among men in the Nenets Autonomous Okrug.
| Variable | Crude Differences between Pechora and Other | Crude Ethnic Differences | Age | BMI | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Islands | Shoina | Amderma | Indiga | Nenets vs. non-Nenets | ||||||||||
| bc * | 95% CI | bc | 95% CI | bc | 95% CI | bc | 95% CI | bc | 95% CI | bc | 95% CI | B * | 95% CI | |
| p, p′-DDE |
|
|
|
|
|
| 0.25 | −0.45; 0.95 |
|
| 0 | −0.02; 0.02 |
|
|
| ∑ DDT | 0.26 | −0.16; 0.69 | 0.44 | −0.07; 0.95 | 0.16 | −0.28; 0.60 |
|
| −0.29 | −0.63; 0.04 | 0.01 | 0.00; 0.02 | 0.03 | −0.01; 0.06 |
| PCB 118 | 0.20 | −0.12; 0.53 | 0.13 | −0.26; 0.52 |
|
|
|
|
|
| 0.01 | 0.00; 0.02 | 0.04 | 0.01; 0.08 |
| PCB 138 |
|
|
|
|
|
| 0.38 | −0.16; 0.91 | −0.08 | −0.50; 0.34 |
|
| 0.04 | −0.01; 0.07 |
| PCB 153 |
|
|
|
|
|
| 0.42 | −0.38; 1.23 | 0.43 | −0.21; 1.08 |
|
| 0.01 | −0.06; 0.09 |
| PCB 180 |
|
|
|
|
|
|
|
| 0.01 | −0.80; 0.82 | 0.02 | −0.01; 0.05 | 0.03 | −0.06; 0.12 |
| ∑ PCB |
|
|
|
|
|
| 0.45 | −0.09; 0.98 | 0.18 | −0.28; 0.63 |
|
| 0.02 | −0.03; 0.08 |
| HCB | 0.25 | −0.28; 0.77 |
|
|
|
|
|
|
|
| 0.01 | −0.01; 0.02 | 0.02 | −0.03; 0.06 |
| β-HCH | 0.04 | −0.46; 0.54 |
|
| 0.30 | −0.22; 0.81 | 0.44 | −0.10; 0.98 | −0.41 | −0.76; −0.05 |
|
|
|
|
* Statistically significant associations are in bold.
Adjusted coefficients (ba) and 95% confidence intervals (CI) for the associations between logarithmically transformed serum concentrations of legacy POPs and selected covariates among men in the Nenets Autonomous Okrug.
| Variable | Adjusted Differences between Pechora and Other | Adjusted Ethnic Differences | Age | BMI | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Islands | Shoina | Amderma | Indiga | Nenets vs. Non-Nenets | ||||||||||
| ba * | 95% CI | ba * | 95% CI | ba * | 95% CI | ba * | 95% CI | ba * | 95% CI | ba * | 95% CI | ba * | 95% CI | |
| p, p′-DDE |
|
|
|
| 0.62 | −0.10; 1.43 | −0.30 | −1.01; 0.41 |
|
| 0.00 | −0.02; 0.01 |
|
|
| ∑ DDT | 0.33 | −0.08; 0.74 | 0.01 | −0.52; 0.54 | −0.32 | −0.78; 0.15 |
|
|
|
| 0.01 | −0.01; 0.02 |
|
|
| PCB 118 | 0.23 | −0.11; 0.56 | 0 | −0.44; 0.43 |
|
|
|
| 0.13 | −0.41; 0.15 | 0.01 | 0.00; 0.02 | 0.02 | −0.01; 0.05 |
| PCB 138 |
|
|
|
|
|
| 0.33 | −0.22; 0.87 | −0.07 | −0.48; 0.33 |
|
| 0.03 | −0.01; 0.07 |
| PCB 153 |
|
|
|
|
|
| 0.70 | −0.12; 1.52 | 0.54 | −0.06; 1.15 |
|
| 0.00 | −0.06; 0.06 |
| PCB 180 |
|
|
|
|
|
|
|
| 0.17 | −0.38; 0.72 |
|
| 0.00 | −0.06; 0.05 |
| ∑ PCB |
|
|
|
|
|
| 0.52 | −0.03; 1.01 | 0.17 | −0.23; 0.57 |
|
| 0.01 | −0.03; 0.05 |
| HCB | 0.20 | −0.32; 0.73 |
|
|
|
|
|
| 0.42 | −0.02; 0.86 | 0.01 | 0.00; 0.02 | 0.02 | −0.02; 0.07 |
| β-HCH | 0.06 | −0.40; 0.52 | 0.39 | −0.21; 0.99 | −0.15 | −0.67; 0.37 | 0.25 | −0.27; 0.76 | −0.30 | −0.68; 0.09 |
|
|
|
|
* Adjusted for age, body mass index, ethnic background and location. Statistically significant associations are in bold.
Figure 2Median serum concentration of individual POPs in men in 2009 [32] and 2018 in Nelmin-Nos, Nenets Autonomous Okrug, Arctic Russia.